Breaking News

Covance Acquires Medaxial

May 20, 2014

Expands global market access offerings

Covance has acquired Medaxial, a communication consultancy that specializes in offering an integrated approach to market access strategy, health economic modeling, and data dissemination services to the pharma, biopharma and medical device industries.
 
Based in London, with offices in NY, Antwerp, and Belgium, Medaxial expands Covance’s market access services currently located in Gaithersburg, MD, Greenfield, IN, San Diego and Sydney. 
 
"Covance is a leader in the rapidly growing sector of market access and reimbursement.  Medaxial, with their proven expertise in optimizing data-driven, solution-focused communication of a medical product's value will further complement our market access offerings," said Marc Ginsky, vice president and general manager, Covance Market Access. "Proactive and effective communication of clinical and economic value is critical to help clients navigate an increasingly complex drug development and payment landscape, as they strive to provide innovative medical products to patients."
 
"Our capabilities and our commitment to client service are in line with Covance's commitment to operational and service excellence," said Paul Mcloughlin, co-founder and Director, Technology and Design, Medaxial. "This acquisition will provide clients with the benefits of a global consultancy group with local expertise."
blog comments powered by Disqus
  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • The Role of Alliances in Modern Drug Development

    The Role of Alliances in Modern Drug Development

    Dr. Claire Madden-Smith, Senior Vice President, Juniper Pharma Services||September 8, 2016
    Combining expertise to get drug candidates through development

  • Successful Method Transfer of Solid Oral Dosage

    Successful Method Transfer of Solid Oral Dosage

    John Frankonis, Ropack Pharma Solutions||June 2, 2016
    The three steps outlined will help guide the process of completing a successful analytical method transfer